Narrative review on the management of moderate-severe atopic dermatitis in pediatric age of the Italian Society of Pediatric Allergology and Immunology (SIAIP), of the Italian Society of Pediatric Dermatology (SIDerP) and of the Italian Society of Pediatrics (SIP)-Reference-Cited by-同舟云学术

Narrative review on the management of moderate-severe atopic dermatitis in pediatric age of the Italian Society of Pediatric Allergology and Immunology (SIAIP), of the Italian Society of Pediatric Dermatology (SIDerP) and of the Italian Society of Pediatrics (SIP)

Published:2022-06-14 Issue:1 Volume:48 Page:
ISSN:1824-7288
Container-title:Italian Journal of Pediatrics
language:en
Short-container-title:Ital J Pediatr

Author:

Galli Elena,Fortina Anna Belloni,Ricci Giampaolo,Maiello Nunzia,Neri Iria,Baldo Ermanno,Berti Irene,Bonamonte Domenico,Capra Lucetta,Carboni Elena,Carello Rossella,Caroppo Francesca,Cavagni Giovanni,Chinellato Iolanda,Cipriani Francesca,Comberiati Pasquale,Diociaiuti Andrea,Di Lernia Vito,Duse Marzia,Filippeschi Cesare,Giannetti Arianna,Giovannini Mattia,Licari Amelia,Marseglia Gian Luigi,Pace Manuela,Patrizi Annalisa,Pajno Giovanni Battista,Peroni Diego,Villani Alberto,Eichenfield Lawrence

Abstract

AbstractCurrently, there are a few detailed guidelines on the overall management of children and adolescents with moderate-severe atopic dermatitis. AD is a complex disease presenting with different clinical phenotypes, which require an individualized and multidisciplinary approach. Therefore, appropriate interaction between primary care pediatricians, pediatric allergists, and pediatric dermatologists is crucial to finding the best management strategy. In this manuscript, members of the Italian Society of Pediatric Allergology and Immunology (SIAIP), the Italian Society of Pediatric Dermatology (SIDerP), and the Italian Society of Pediatrics (SIP) with expertise in the management of moderate-severe atopic dermatitis have reviewed the latest scientific evidence in the field. This narrative review aims to define a pathway to appropriately managing children and adolescents with moderate-severe atopic dermatitis.

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Link

https://link.springer.com/content/pdf/10.1186/s13052-022-01278-7.pdf

Reference258 articles.

1. Thomas KS, Apfelbacher CA, Chalmers JR, Simpson E, Spuls PI, Gerbens LAA, et al. Recommended core outcome instruments for health-related quality of life, long-term control and itch intensity in atopic eczema trials: results of the HOME VII consensus meeting. Br J Dermatol. 2020. https://doi.org/10.1111/bjd.19673. Epub ahead of print.

2. Severity scoring of atopic dermatitis: the SCORAD index. Consensus report of the European task force on atopic dermatitis. Dermatology. 1993;186:23–31.

3. Hanifin JM, Thurston M, Omoto M, EASI Evaluator Group, et al. The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. Exp Dermatol. 2001;10:11–8.

4. Conic RZ, Tamashunas NL, Damiani G, Fabbrocini G, Cantelli M, Young Dermatologists Italian Network, & Bergfeld, W. F. (2020). Comorbidities in pediatric alopecia areata. J Eur Acad Dermatol Venereol. 2020;34(12):2898–901.

5. Perugia C, Saraceno R, Ventura A, et al. Atopic dermatitis and dental manifestations. G Ital Dermatol Venereol. 2017;152:122–5.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Focus on biological therapies in pediatric allergy;Global Pediatrics;2024-03

2. Advances for pediatricians in 2022: allergy, anesthesiology, cardiology, dermatology, endocrinology, gastroenterology, genetics, global health, infectious diseases, metabolism, neonatology, neurology, oncology, pulmonology;Italian Journal of Pediatrics;2023-09-08

3. Pearls and Pitfalls of Weaning an Infant with Severe Atopic Dermatitis and Sensitization/Allergy to Food;Journal of Clinical Medicine;2023-06-07

4. Challenges in Textile Contact Dermatitis;Current Dermatology Reports;2023-01-25

5. Upadacitinib for moderate-to-severe atopic dermatitis, in adults and adolescents 12 years and older: review of international and Japanese populations;Expert Review of Clinical Immunology;2022-11-24